Alimera Sciences (ALIM) Debt to Equity Ratio

Price: $5.54
Market Cap: $301.29M
Avg Volume: 866.83K
Country: US
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Beta: 1.245
52W Range: $2.606-5.65
Website: Alimera Sciences

Debt to Equity Ratio

Alimera Sciences's debt to equity ratio indicates the proportion of equity and debt the company uses to finance its assets:

  • Annual: 1.40
  • Quarterly: 1.80
  • TTM: 1.80

Other Key Debt Metrics

These metrics provide additional insights into Alimera Sciences's financial leverage and its ability to meet financial obligations:

  • Debt Ratio - indicates the proportion of a company's assets that are financed through debt:
    • Annual: 42.01%
    • Quarterly: 46.37%
    • TTM: 46.37%
  • Debt to Assets Ratio - shows the proportion of a company's assets that are financed by debt:
    • Annual: 42.01%
    • Quarterly: 46.37%
    • TTM: 46.37%

These financial metrics offer a comprehensive view of Alimera Sciences's debt structure and financial health. By comparing these ratios with industry benchmarks, investors can better understand the company's leverage and risk profile.

Annual Debt to Equity Ratio

1.40

Quarterly Debt to Equity Ratio

1.80

TTM Debt to Equity Ratio

1.80

Alimera Sciences Historical Debt to Equity Ratio
16.0016.008.008.000.000.00-8.00-8.00-16.00-16.00-24.00-24.00Debt to Equity Ratio20152015201620162017201720182018201920192020202020212021202220222023202320242024
Historical Debt Ratio
152.41%152.41%101.61%101.61%50.80%50.80%0.00%0.00%Debt Ratio20152015201620162017201720182018201920192020202020212021202220222023202320242024
Historical Debt to Assets Ratio
152.41%152.41%101.61%101.61%50.80%50.80%0.00%0.00%Debt to Assets Ratio20152015201620162017201720182018201920192020202020212021202220222023202320242024

Alimera Sciences Historical Debt to Equity Ratio

The table below shows various debt metrics for each year, with the latest data available for the last fiscal year 2023.

Year Debt to Equity Ratio Debt Ratio Debt to Assets Ratio
2023 1.40 42.01% 42.01%
2022 -2.11 103.27% 103.27%
2021 -16.54 73.62% 73.62%
2020 -5.50 86.30% 86.30%
2019 -8.70 76.84% 76.84%
2018 13.91 70.00% 70.00%
2017 2.30 57.35% 57.35%
2016 1.29 47.11% 47.11%
2015 1.23 45.92% 45.92%
2014 0.69 31.16% 31.16%

Related Metrics

Explore detailed financial metrics and analysis for ALIM.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio